National Rollout of PromarkerD and PromarkerEso
Proteomics International Laboratories Ltd (ASX: PIQ) is pleased to announce that the national rollout of Promarker D and Promarker Eso blood tests, in collaboration with Healius Limited (ASX: HLS) (“Healius”), is scheduled to commence on Monday, 26 October 2026.
Highlights
-
National rollout of Promarker D and Promarker Eso through Healius, Proteomics International’s exclusive Australian pathology distribution partner, scheduled to commence on Monday, 26 October 2026.
-
Field sales teams have completed training in both tests, with joint sales and marketing plans agreed to support clinician education, awareness and appropriate referrals.
-
Systems and operational integration will enable patient blood collection and payment through Healius collection centres.
-
National rollout of Promarker D and Promarker Eso experience to support commercial release of Promarker®Endo in FY27 Q3 (January–March 2027), subject to clinical deployment and applicable quality, accreditation and regulatory requirements.
View ASX announcement: here